Bills › 91st General Assembly
Relating to the controlled substance crystalline polymorph psilocybin
Sponsored by Rep. Ann Meyer (R)
Where it is now
- Done: IntroducedJanuary 14, 2025
- Done: SubcommitteeJanuary 22, 2025
- Done: House committeeFebruary 11, 2025
- Skipped: Passes the HouseContinued as HF 383
- Next: Senate committee
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Became HF 383 → Its progress continues under the new number. Go to HF 383 What’s a funnel?
What’s in it
AI summary If the FDA approves a specific form of the drug psilocybin, Iowa will change how it is classified under state law. Once this happens, doctors would be allowed to prescribe and sell the drug as a medicine. This change would move the substance from a highly restricted category to a different legal status.1
Read the official explanation
This bill relates to the controlled substance crystalline polymorph psilocybin.201(4)(s)).204(4), a drug that contains the pharmaceutical composition of crystalline polymorph psilocybin shall be immediately removed from schedule I upon its approval by the United States food and drug administration and rescheduled based upon the recommendations of the United States food and drug administration and its listing in the federal Controlled Substances Act. it shall be lawful to prescribe, distribute, and market the pharmaceutical composition of crystalline polymorph psilocybin. Current penalties for the possession of psilocybin range from a serious misdemeanor to a class “B” felony.
House subcommittee
Named January 22, 2025. On February 6, 2025 it recommended passage.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Family tree
Study bill
91st General Assembly